The mortality rate from influenza in the United States is by far highest among those aged 65 years and older. During the 2022-2023 flu season the mortality rate from influenza for this age group was around 26.6 per 100,000 population.
The burden of influenza The impact of influenza in the U.S. varies from season to season, but in the 2022-2023 flu season there were an estimated 31 million cases. These cases resulted in around 360,000 hospitalizations. Although most people recover from influenza without requiring medical treatment, the disease can be deadly for young children, the elderly, and those with weakened immune systems or chronic illnesses. During the 2022-2023 flu season, around 21,000 people in the U.S. lost their lives due to influenza.
Impact of vaccinations The most effective way to prevent influenza is to receive a yearly vaccination at the beginning of flu season. Flu vaccines are safe and can greatly reduce the burden of the disease. During the 2022-2023 flu season vaccinations prevented around 2,479 deaths among those aged 65 years and older. Although flu vaccines are usually cheap and easily accessible, every year a large share of the population in the U.S. still does not get vaccinated. For example, during the 2021-2022 flu season only about 37 percent of those aged 18 to 49 years received a flu vaccination.
The burden of influenza in the United States can vary from year to year depending on which viruses are circulating, how many people receive an influenza vaccination, and how effective the vaccination is in that particular year. During the 2019-2020 flu season, around 25,000 people lost their lives to the disease. Although most people recover from influenza without needing medical care, the disease can be deadly among young children, the elderly, and those with weakened immune systems or chronic illnesses.
Deaths due to influenza Even though most people recover from influenza without medical care, influenza and pneumonia can be deadly, especially for older people and those with certain preexisting conditions. Influenza is a common cause of pneumonia and although most cases of influenza do not develop into pneumonia, those that do are often more severe and more deadly. Deaths due to influenza are most common among the elderly, with a mortality rate of around 7.4 per 100,000 population during the 2021-2022 flu season. In comparison, the mortality rate for those aged 50 to 64 years was just 1.2 per 100,000 population.
Flu vaccinations The most effective way to prevent influenza is to receive a yearly influenza vaccination. These vaccines have proven to be safe and are usually cheap and easily accessible. Nevertheless, every year a large share of the population in the United States still fails to get vaccinated against influenza. For example, in the 2021-2022 flu season only 37 percent of those aged 18 to 49 years received a flu vaccination. Unsurprisingly, children and the elderly are the most likely to get vaccinated. It is estimated that during the 2021-2022 flu season vaccinations prevented over 618 thousand influenza cases among children aged 6 months to 4 years.
During the 2022-2023 flu season in the United States, around 21,401 people died from influenza. The vast majority of deaths due to influenza occur among the elderly, with those aged 65 years and older accounting for 15,399 deaths during the 2022-2023 flu season. During this time, the mortality rate from influenza among those aged 65 years and older was around 26.6 per 100,000 population, compared to a mortality rate of .7 per 100,000 population among those aged 18 to 49 years. Influenza deaths Although most people recover from influenza without the need of medical care, influenza and pneumonia are still major causes of death in the United States. Influenza is a common cause of pneumonia and cases in which influenza develops into pneumonia tend to be more severe and more deadly. However, the impact of influenza varies from year to year depending on which viruses are circulating. For example, during the 2017-2018 flu season around 51,000 people died due to influenza, whereas in 2022-2023 total deaths amounted to 21,000. Preventing death The most effective way to prevent influenza is to receive a yearly influenza vaccination. These vaccines have proven to be safe and are usually cheap and easily accessible. Each year, flu vaccinations prevent thousands of influenza cases, hospitalizations and deaths. It was estimated that during the 2022-2023 flu season, vaccinations prevented the deaths of around 2,479 people aged 65 years and older.
Following the outbreak of the H1N1 influenza pandemic of 1918, which came to be known as the Spanish Flu, the number of deaths due to influenza and pneumonia soared. Pneumonia was caused either by the influenza or by a bacterial superinfection that took hold due to the patient's weakened state as a result of the influenza, for this reason, influenza deaths and pneumonia deaths were recorded together as one. Pennsylvania had the highest mortality rate due to the pandemic, where there were over 880 fatalities per 100,000 people; meaning that approximately 0.9 percent of the state's population died from the Spanish Flu pandemic in 1918.
When compared with the 1915 mortality rates, many states, such as California and Pennsylvania, saw their mortality rate due to influenza and pneumonia increase five-fold by 1818, which was the worst year of the pandemic. While the mortality rate decreased significantly in the year 1919, there was no US state where it fell to it's pre-pandemic level, and the 1919 mortality rate was still double the pre-pandemic rate in some states such as California, South Carolina and Washington.
Influenza and pneumonia caused around 12.3 deaths in the U.S. per 100,000 population in 2019. Influenza and pneumonia are among the leading causes of death in the United States, accounting for around 1.6 percent of all deaths in 2020. Influenza, or the flu, is a viral infection that is highly contagious and especially common in the winter season. Influenza is a common cause of pneumonia, although most cases of the flu do not develop into pneumonia. Pneumonia is an infection or inflammation of the lungs and is particularly deadly among young children and the elderly.
Influenza cases
Influenza is very common in the United States, with an estimated 35 million cases reported in 2019-2020. Common symptoms of the flu include cough, fever, runny or stuffy nose, sore throat and headache. Symptoms can be mild but can also be severe enough to require medical attention. In 2019-2020, there were around 16 million influenza-related medical visits in the United States.
Prevention
To prevent contracting the flu people can take everyday precautions such as regularly washing their hands and avoiding those who are sick, but the best way to prevent the flu is by receiving the flu vaccination every year. Receiving a flu vaccination is especially important for young children and the elderly as they are most susceptible to flu complications and associated death. In 2021, around 75 percent of those aged 65 years and older received a flu vaccine, while only 38 percent of those aged 18 to 49 years had done so.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
In 2021, there were four death cases caused by the influenza virus in China. The death rate of the virus amounted to approximately 0.0003 out of ten million people. Influenza, commonly known as "flu", is a highly contagious respiratory disease caused by influenza A or B viruses and can be prevented by vaccines. It should be noted that the Chinese health authorities calculate death cases for infectious diseases differently, counting only patients who died directly from the infectious disease.
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Australia Influenza Mortality jumped by 8% in 2019, from a year earlier.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
*Bold figures correspond to significant estimates.
In 2023, the number of deaths from influenza in Japan decreased to 1383 cases, which marked an increase compared to just 24 cases in the previous year. The death rate from influenza amounted to 1.1 death cases per 100,000 inhabitants in 2023.
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Results data for the thesis on estimating the age-, sex-, cause-specific excess mortality during the COVID-19 pandemic in Hong Kong and South Korea.Thesis abstractBackgroundFew studies used a consistent methodology and adjusted for the risk of influenza-like illness (ILI) in historical mortality trends when estimating and comparing the cause-specific excess mortality (EM) during the COVID-19 pandemic. Previous studies demonstrated that excess mortality was widely reported from CVD and among the elderly. This study aims to estimate and compare the overall, age-, sex-, and cause-specific excess mortality during the COVID-19 pandemic in Hong Kong (HK) and South Korea (SK) with consideration of the impact of ILI.MethodsIn this population-based study, we first fitted a generalized additive model to the monthly mortality data from Jan 2010 to Dec 2019 in HK and SK before the COVID-19 pandemic. Then we applied the fitted model to estimate the EM from Jan 2020 to Dec 2022. The month index was modelled with a natural cubic spline. Akaike information criterion (AIC) was used to select the number of knots for the spline and inclusion of covariates such as monthly mean temperature, absolute humidity, ILI consultation rate, and the proxy for flu activity.FindingsFrom 2020 to 2022, the EM in HK was 239.8 (95% CrI: 184.6 to 293.9) per 100,000 population. Excess mortality from respiratory diseases (RD) (ICD-10 code: J00-J99), including COVID-19 deaths coded as J98.8, was 181.3 (95% CrI: 149.9 to 210.4) per 100,000. Except for RD, the majority of the EM in HK was estimated from cardiovascular diseases (CVD) (22.4% of the overall EM), influenza and pneumonia (16.2%), ischemic heart disease (8.9%), ill-defined causes (8.6%) and senility (6.7%). No statistically significant reduced deaths were estimated among other studied causes.From 2020 to 2022, the EM in SK was 204.7 (95% CrI: 161.6 to 247.2) per 100,000 population. Of note, COVID-19 deaths in SK were not included in deaths from RD but were recorded with the codes for emergency use as U07.1 or U07.2. The majority of the EM was estimated from ill-defined causes (32.0% of the overall EM), senility (16.6%), cerebrovascular disease (6.8%) and cardiovascular diseases (6.1%). Statistically significant reduction in mortality with 95 CrI lower than zero was estimated from vascular, other and unspecified dementia (-26.9% of expected deaths), influenza and pneumonia (-20.7%), mental and behavioural disorders (-18.8%) and respiratory diseases (-7.7%).InterpretationExcluding RD in HK which includes COVID-19 deaths, the majority of the EM in HK and SK was from CVD and senility. Mortality from influenza and pneumonia was estimated to have a statistically significant increase in HK but a decrease in SK probability due to different coding practices. HK had a heavier burden of excess mortality in the elderly age group 70-79 years and 80 years or above, while SK had a heavier burden in the age group of 60-69 years. Both HK and SK have a heavier burden of excess mortality from males than females. Better triage systems for identifying high-risk people of the direct or indirect impact of the epidemic are needed to minimize preventable mortality.
TABLE III. Deaths in 122 U.S. cities - 2014.
122 Cities Mortality Reporting System — Each week, the vital statistics offices of 122 cities across the United States report the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days –1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and ≥ 85 years).
FOOTNOTE:
U: Unavailable. —: No reported cases.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
More information on Flu Activity & Surveillance is available at http://www.cdc.gov/flu/weekly/fluactivitysurv.htm.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
*Bold figures correspond to significant estimates.
In 2022, the highest death rate from influenza and pneumonia in Canada per 100,000 population was reported among those aged 90 years and older, with around 588 deaths. Individuals between 85 and 89 years followed, with a mortality rate from influenza and pneumonia of almost 210 deaths per 100,000 people. This statistic displays the death rate from influenza and pneumonia per 100,000 population in Canada during 2022, by age.
This file contains the complete set of data reported to 122 Cities Mortality Reposting System. The system was retired as of 10/6/2016. While the system was running each week, the vital statistics offices of 122 cities across the United States reported the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days - 1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and - 85 years). U:Unavailable. - : No reported cases.* Mortality data in this table were voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included. Total includes unknown ages. More information on Flu Activity & Surveillance is available at http://www.cdc.gov/flu/weekly/fluactivitysurv.htm.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Risk of death is estimated based on the number of influenza related deaths per 100,000 subpopulation for the specific age and risk groups. Total deaths is estimated based on the proportion of influenza related deaths for the specific age and risk groups among total influenza related deaths. Net benefits are the difference in cost due to improved health outcomes from vaccination and the vaccination cost. Return on investment is the gain in net benefits relative to the vaccination cost, that is, dollars saved per $1 investment in vaccine intervention.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Wave 2 Influenza mortality rates for the three settlement types in Malta.
In 2023, there were 15.9 deaths from influenza and pneumonia in Canada per 100,000 population. Influenza, more commonly known as the flu, is a highly contagious viral infection and frequent cause of pneumonia. Pneumonia is a more serious infection of the lungs and is particularly deadly among young children, the elderly, and those with certain chronic conditions. Vaccination There exist vaccines for both influenza and pneumonia, and although effectiveness varies, vaccination remains one of the best ways to prevent these illnesses. Nevertheless, only around 34 percent of Canadians received an influenza vaccination in the past year in 2022. The most common reason why Canadian adults received the influenza vaccination was to prevent infection or because they did not want to get sick. Pneumonia hospitalization Every year tens of thousand of people in Canada are hospitalized for pneumonia. In 2021-2022, there were over 63,000 emergency room visits for pneumonia in Canada, a substantial decrease from the numbers recorded from 2010 to 2020. Perhaps unsurprisingly, those aged 65 years and older account for the highest number of emergency room visits for pneumonia. The median length of stay for emergency department visits for pneumonia in Canada has increased in recent years, with the median length of stay around 330 minutes in 2021-2022.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
1918/19 influenza death information by settlement for Malta.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
N—estimated number of deaths CI—confidence interval, HIV—human immunodeficiency virus*Age-adjusted.Incidence of mortality for influenza-associated severe acute respiratory illness per 100,000 person years by HIV status in Soweto, South Africa, 2009–2013.
The mortality rate from influenza in the United States is by far highest among those aged 65 years and older. During the 2022-2023 flu season the mortality rate from influenza for this age group was around 26.6 per 100,000 population.
The burden of influenza The impact of influenza in the U.S. varies from season to season, but in the 2022-2023 flu season there were an estimated 31 million cases. These cases resulted in around 360,000 hospitalizations. Although most people recover from influenza without requiring medical treatment, the disease can be deadly for young children, the elderly, and those with weakened immune systems or chronic illnesses. During the 2022-2023 flu season, around 21,000 people in the U.S. lost their lives due to influenza.
Impact of vaccinations The most effective way to prevent influenza is to receive a yearly vaccination at the beginning of flu season. Flu vaccines are safe and can greatly reduce the burden of the disease. During the 2022-2023 flu season vaccinations prevented around 2,479 deaths among those aged 65 years and older. Although flu vaccines are usually cheap and easily accessible, every year a large share of the population in the U.S. still does not get vaccinated. For example, during the 2021-2022 flu season only about 37 percent of those aged 18 to 49 years received a flu vaccination.